Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma

Asthma is a chronic inflammatory disorder of the airways where bacteria may act as protagonists of chronic inflammation. Little is known about the relation of airway inflammation to the presence of specific bacterial taxa. We sought to describe the sputum microbiome in adults with poorly controlled asthma. DNA was extracted from induced sputum and microbial communities were profiled using 16S rRNA pyrosequencing. Bacterial species were characterised, and the relationship between microbial populations, asthma inflammatory subtypes and other covariates was explored. Real-time PCR was used to identify Tropheryma whipplei and Haemophilus influenzae in sputum. Adults with neutrophilic asthma had reduced bacterial diversity and species richness. Tropheryma was identified and confirmed with real-time PCR in 12 (40%) participants. Haemophilus occurred most often in a group of younger atopic males with an increased proportion of neutrophils. PCR confirmed the presence of H. influenzae in 35 (76%) participants with poorly controlled asthma. There are phenotype-specific alterations to the airway microbiome in asthma. Reduced bacterial diversity combined with a high prevalence of H. influenzae was observed in neutrophilic asthma, whereas eosinophilic asthma had abundant T. whipplei. There are phenotype-specific alterations to the airway microbiome in asthma which may modulate local inflammation http://ow.ly/UbB9k

[1]  Joseph R Arron,et al.  The airway microbiome in patients with severe asthma: Associations with disease features and severity. , 2015, The Journal of allergy and clinical immunology.

[2]  H. Boushey,et al.  Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease , 2014, Journal of Clinical Microbiology.

[3]  M. McGuckin,et al.  A novel microbiota stratification system predicts future exacerbations in bronchiectasis. , 2014, Annals of the American Thoracic Society.

[4]  Ronald E Gangnon,et al.  Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. , 2014, The Journal of allergy and clinical immunology.

[5]  Barbara A. Bailey,et al.  Clinical Insights from Metagenomic Analysis of Sputum Samples from Patients with Cystic Fibrosis , 2013, Journal of Clinical Microbiology.

[6]  Donald Y M Leung,et al.  The effects of airway microbiome on corticosteroid responsiveness in asthma. , 2013, American journal of respiratory and critical care medicine.

[7]  S. Phipps,et al.  Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.

[8]  Emily S. Charlson,et al.  Widespread colonization of the lung by Tropheryma whipplei in HIV infection. , 2013, American journal of respiratory and critical care medicine.

[9]  Patrick D Schloss,et al.  Comparison of the respiratory microbiome in healthy nonsmokers and smokers. , 2013, American journal of respiratory and critical care medicine.

[10]  Dean Billheimer,et al.  Asthma-associated differences in microbial composition of induced sputum. , 2013, The Journal of allergy and clinical immunology.

[11]  Richard E. Isaacson,et al.  The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease , 2012, PloS one.

[12]  D. Raoult,et al.  First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications. , 2012, The Journal of infection.

[13]  N. Zhong,et al.  Bacteria in sputum of stable severe asthma and increased airway wall thickness , 2012, Respiratory Research.

[14]  J. Curtis,et al.  Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.

[15]  Tanja Woyke,et al.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. , 2011, The Journal of allergy and clinical immunology.

[16]  D. Raoult,et al.  Tropheryma whipplei in Patients with Pneumonia , 2010, Emerging infectious diseases.

[17]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[18]  L. Wood,et al.  Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia , 2010, Free radical research.

[19]  David W H Riches,et al.  Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. , 2008, The Journal of allergy and clinical immunology.

[20]  N. Pace,et al.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.

[21]  J. Douwes,et al.  Innate immune activation in neutrophilic asthma and bronchiectasis , 2007, Thorax.

[22]  T. Shimoda,et al.  Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  B. Del-Río-Navarro,et al.  Effect of salmeterol and salmeterol plus beclomethasone on saliva flow and IgA in patients with moderate-persistent chronic asthma. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[25]  A. Cripps,et al.  Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. , 1998, American journal of respiratory and critical care medicine.

[26]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[27]  G. Guyatt,et al.  Measuring quality of life in asthma. , 1993, The American review of respiratory disease.

[28]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.